 |
|
|
|
 |
|
|
| Article 1 to 5 out of 5 concerning Cambrex Bio Science Walkersville, Inc.
|
-
Cambrex Corporation and Cytori Therapeutics Enter Into Collaboration to Provide Adipose Derived Stem Cell Research Products
(16 Jun 2006)
Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex Corporation, and Cytori Therapeutics announced that they have entered into a strategic marketing agreement to provide adipose-derived stem cell products globally for use in basic and ...
-
Cambrex Licenses Cell Line to Chugai Pharmaceutical Co.
(23 Feb 2006)
Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex, announced that its client Chugai Pharmaceutical Co., Ltd. completed their assessment of certain of its Clonetics(R) Conditionally Immortalized Cell Lines under the previously announced ...
-
Geron and Cambrex Announce Contract Manufacturing Arrangement for cGMP Production of GRNVAC1 for Clinical Trials
(15 Feb 2006)
Geron Corporation and Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex Corporation, announced an agreement for the manufacture of Geron's GRNVAC1 telomerase vaccine. The agreement provides for the transfer of Geron's vaccine ...
-
Cambrex Licenses Cell Lines to Chugai Pharmaceutical Co.
(05 Oct 2005)
Cambrex Bioscience Walkersville, Inc., a subsidiary of Cambrex Corporation, announced that they have signed an evaluation license agreement with Chugai Pharmaceutical Co., Ltd. for the use of certain Cambrex Clonetics® Conditionally Immortalized ...
-
New Gene Expression Data for Cambrex Primary Cells
(06 Jun 2005)
Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex Corporation, announced the availability of gene expression data and summary analyses for several primary human cell types. A comparison of the gene expression patterns between the ...
|
|
|
|
|
Top
